Related references
Note: Only part of the references are listed.Increased Plasma Soluble uPAR Level Is a Risk Marker of Respiratory Cancer in Initially Cancer-Free Individuals
Anne Langkilde et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in Crimean-Congo hemorrhagic fever
Gurdal Yilmaz et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study
R. Huttunen et al.
JOURNAL OF INTERNAL MEDICINE (2011)
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population
J. Eugen-Olsen et al.
JOURNAL OF INTERNAL MEDICINE (2010)
suPAR: The molecular crystal ball
Maria Thuno et al.
DISEASE MARKERS (2009)
Baseline C-Reactive Protein Is Associated With Incident Cancer and Survival in Patients With Cancer
Kristine H. Allin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
High mortality risk among individuals assumed to be TB-negative can be predicted using a simple test
Paulo Rabna et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2009)
Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor
K. Kofoed et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2008)
Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study
Kristian Kofoed et al.
CRITICAL CARE (2007)
High plasma levels of intact and cleaved soluble urokinase receptor reflect immune activation and are independent predictors of mortality in HIV-1-infected patients
SR Ostrowski et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2005)
Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome
SR Ostrowski et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Interleukin-6 infusion during human endotoxaemia inhibits in vitro release of the urokinase receptor from peripheral blood mononuclear cells
SR Ostrowski et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2005)
The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality
P Wittenhagen et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
uPAR: A versatile signalling orchestrator
F Blasi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Share Paper
